-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
EXCLUSIVE: Psyched Wellness CEO Breaks Down Mushroom Strategy, From 'Alice In Wonderland' To The Checkout Aisle
Psyched Wellness Ltd (OTCQB:PSYCF) plans to begin selling a psychoactive mushroom extract this summer that's never been scheduled as a drug in the U.S.
It's derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol.
"Everyone knows what this mushroom is by sight. You've seen 'Alice in Wonderland.' You've seen it on your phone. It's the mushroom emoji," Psyched Wellness CEO Jeffrey Stevens told the inaugural Benzinga Psychedelics Capital Conference Tuesday in Miami Beach.
Here's what psychedelics investors need to know.
The Product: Psyched's first product, a tincture named Calm, will be sold in the U.S. as a food supplement and is intended as a sleep aid.
It's built on Psyched's proprietary amanita muscaria extract AME-1. The extraction is key: the reason the mushroom never caught on from a recreational standpoint is that it would make you ill to eat it without any extraction process, the CEO said.
"You can't put any patents on a mushroom, but you certainly can on the processes," Stevens said.
Long used by indigenous groups, muscimol acts on the GABAA receptors and is a powerful compound, he said.
"The regulatory landscape for this mushroom is quite unique," Stevens said, adding that it can be sold over the counter.
What's Next For Psyched Wellness: The distribution strategy for Psyched's first-to-market product Calm targets over 200,000 retail outlets, said CCO Matthew Singh.
The company is developing beverage, pain management, anti-inflammatory, beauty and cosmetic products, slow-release capsules, a tea steeping bag and topical creams for future release, said Singh, who previously worked with Coca-Cola Co (NYSE:KO), Red Bull and Vital Pharmaceuticals.
Psyched is planning a commercial vertical with wholesale white label and private label applications of the AME-1 extract, he said.
"We have a wide assortment of what we want to do with this mushroom and its incredible healing power."
Psyched Wellness Ltd (OTCQB:PSYCF) plans to begin selling a psychoactive mushroom extract this summer that's never been scheduled as a drug in the U.S.
心智健康有限公司(场外交易代码:PSYCF)计划今年夏天开始销售一种具有精神活性的蘑菇提取物,这种提取物在美国从未被列为药物。
It's derived from amanita muscaria, an instantly recognizable, red-capped fungi, and its active ingredient muscimol.
它来自毒蛾,一种一眼就能辨认出来的红帽真菌,及其活性成分麝香酚。
"Everyone knows what this mushroom is by sight. You've seen 'Alice in Wonderland.' You've seen it on your phone. It's the mushroom emoji," Psyched Wellness CEO Jeffrey Stevens told the inaugural Benzinga Psychedelics Capital Conference Tuesday in Miami Beach.
“每个人都一眼就知道这个蘑菇是什么。你看过《爱丽丝梦游仙境》。你在手机上看到过它。这是蘑菇表情符号,”心理健康首席执行官说杰弗里·史蒂文斯周二在迈阿密海滩举行的首届Benzinga迷幻资本会议上说。
Here's what psychedelics investors need to know.
以下是迷幻药投资者需要知道的事情。
The Product: Psyched's first product, a tincture named Calm, will be sold in the U.S. as a food supplement and is intended as a sleep aid.
产品:安琪的第一款产品是一种名为Calm的药酒,将作为食品补充剂在美国销售,旨在帮助睡眠。
It's built on Psyched's proprietary amanita muscaria extract AME-1. The extraction is key: the reason the mushroom never caught on from a recreational standpoint is that it would make you ill to eat it without any extraction process, the CEO said.
它是建立在安琪专有的鹅膏菌提取物AME-1上的。提取是关键:从娱乐的角度来看,蘑菇从未流行起来的原因是,不经过任何提取过程就吃了它会让你生病,这位首席执行官说。
"You can't put any patents on a mushroom, but you certainly can on the processes," Stevens said.
史蒂文斯说:“你不能为蘑菇申请任何专利,但你当然可以为其工艺申请专利。”
Long used by indigenous groups, muscimol acts on the GABAA receptors and is a powerful compound, he said.
他说,麝香酚长期被土著群体使用,作用于GABAA受体,是一种强大的化合物。
"The regulatory landscape for this mushroom is quite unique," Stevens said, adding that it can be sold over the counter.
“这种蘑菇的监管环境是非常独特的,”史蒂文斯说,并补充说,它可以在柜台销售。
What's Next For Psyched Wellness: The distribution strategy for Psyched's first-to-market product Calm targets over 200,000 retail outlets, said CCO Matthew Singh.
心理健康的下一步是什么:CCO表示,Pecked的首个上市产品Calm的分销战略瞄准了20多万家零售店马修·辛格.
The company is developing beverage, pain management, anti-inflammatory, beauty and cosmetic products, slow-release capsules, a tea steeping bag and topical creams for future release, said Singh, who previously worked with Coca-Cola Co (NYSE:KO), Red Bull and Vital Pharmaceuticals.
辛格说,该公司正在开发饮料、止痛、消炎、美容和美容产品、缓释胶囊、浸茶袋和局部霜,以供未来发布可口可乐公司(纽约证券交易所代码:KO)、红牛和VITAL制药。
Psyched is planning a commercial vertical with wholesale white label and private label applications of the AME-1 extract, he said.
他说,Enched正在计划一个商业垂直领域,批发白色标签和AME-1提取物的私人标签应用。
"We have a wide assortment of what we want to do with this mushroom and its incredible healing power."
“我们有各种各样的想法来处理这种蘑菇及其不可思议的治愈能力。”
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧